There is now enough genomic data from the US and Germany to repeat this approach to estimating Omicron-specific rate of epidemic spread. Here, we observe similar initial rapid spread in the US and Germany. 1/10
As before, we partition case counts from @OurWorldInData using sequences from @GISAID into estimated Omicron, Delta and other cases, and we use this partitioning to infer variant-specific Rt and epidemic growth rate r (methods and code here github.com/blab/rt-from-f…). 2/10
We find that logistic growth of Omicron sequence fraction looks similar between the UK, the US and Germany with roughly 1% of sequenced cases in all three countries being Omicron on Dec 1. 3/10
Combining this with case count data in @marlinfiggins model framework estimates Omicron Rt at 3.1 for Germany, 3.0 for the US and 4.8 for the UK but with wide 80% credible intervals. 4/10
To avoid assumptions of generation interval, we also estimate epidemic growth rate r across countries, with r = 0.19 in Germany, r = 0.19 in the US and r = 0.27 in the UK. This corresponds to doubling times on Dec 1 of 3.7 days, 3.7 days and 2.5 days respectively. 5/10
These numbers differ somewhat from what I presented on Thursday primarily due to exact model choice. On Thursday I presented estimates for South Africa and the UK from the "free Rt" model, whereas today's estimates are from the "fixed growth" model. 6/10
Basically, the "free Rt" model treats each variant separately and tries to estimate an independent Rt trajectory for each, while the "fixed growth" model estimates a single Rt trajectory and inflates variant-specific Rt by a fixed value. 7/10
We've observed that the "fixed growth" model is more robust during initial spread while variant is still rare and so we've switched to this model for primary analysis. Full details on model differences are available in the technical report at bedford.io/papers/figgins…. 8/10
I've also pulled back data to 10 days before present rather than the previous 7 days to better correspond to lags in sequence deposition from the US and Germany. @marlinfiggins and I plan to keep updating figures at github.com/blab/rt-from-f… every day as new data arrives. 9/10
It's interesting that so far Rt values appear quite similar across countries. However, as time accrues and more countries collect sequence data, we may be able to make some systematic comparisons in rate of spread across countries. 10/10
• • •
Missing some Tweet in this thread? You can try to
force a refresh
It seems that the common assumption has been that Omicron will displace Delta, just as Delta displaced Alpha, Beta, Gamma, etc... before it. This may well be the case, but it's by no means definite. 1/15
Depending on Omicron's mix of intrinsic transmissibility and immune escape (and what happens with continued evolution), we could see: 1. Displacement of Delta by Omicron 2. Long-term co-circulation 3. Omicron wave followed by resurgence of Delta and extinction of Omicron
2/15
Intuitively, the more immune escape Omicron has from Delta-specific immunity the more the two variants have distinct ecological niches and so are able to co-exist without stepping on each other's toes. 3/15
We've seen exceptionally rapid spread of Omicron in South Africa. Although we should expect this rapid spread to follow in other geographies, we've mostly lacked data to confirm this until recently. 1/21
) and extremely strong genomic surveillance by @CovidGenomicsUK, we should have early data from the UK about rate of spread outside of South Africa. 2/21
The UK is sequencing between 5000 and 8000 viruses everyday. Although turnaround times are fast, necessary processing delays permit a view that's basically lagged by ~7 days. Today, I have a strong view of Dec 1 data in @GISAID, but Dec 2 has much less data available to me. 3/21
As the Omicron epidemic continues to expand in South Africa and as case counts and sequencing data continues to come in, we can better estimate the current transmission rate of Omicron. 1/19
Here, I am focused on two approaches to estimate this transmission rate. One is growth in frequency of Omicron compared to Delta in Gauteng and the other is growth in case counts attributable to Omicron. 2/19
If one variant is fitter than anther variant and is transmitting faster in the population we should expect to see it increase in frequency following logistic growth. See @TWenseleers for discussion of this approach. 3/19
Omicron appears to have emerged around Oct 1 and has taken 8 weeks of exponential growth to "suddenly" have sizable impacts on case counts and hospitalizations in Gauteng. This "suddenly" is the nature of exponential growth. 2/6
Exports from the South African epidemic are now being detected across the world and these exports are sparking local transmission. Figure from nextstrain.org/groups/blab/nc… using data generously shared to @GISAID. 3/6
Following up here with speculative estimates of the rate of spread of Omicron and a stab at how to apportion this rapid rate of spread between intrinsic transmissibility and immune escape. 1/18
Monday's post was mainly meant to emphasize that observed rapid spread of Omicron can be influenced by both intrinsic transmissibility and immune escape. Here, I'll try to put (speculative) numbers on this rate of spread. 2/18
Key datapoints include rapid displacement of existing Delta viruses by Omicron in Gauteng and South Africa. Estimates of logistic growth rate here by @TWenseleers imply Omicron has ~5X current transmission rate of Delta. 3/18
I think there's perhaps been some confusion regarding transmissibility vs immune escape in Omicron. The apparent rapid increase in frequency of Omicron in Gauteng does not mean that Omicron is necessarily more intrinsically transmissible than Delta. 1/15
This diagram shows estimated increase in intrinsic transmissibility from work by @marlinfiggins (
) along with fold drop in neutralization titer compiled from Uriu et al (biorxiv.org/content/10.110…) and similar papers. 2/15
We see that previous variants have showed only modest potential for escape from immunity engendered by vaccination or infection with circulating SARS-CoV-2 viruses, but have varied considerably in their intrinsic transmissibility with Delta outpacing others. 3/15